Equity | 6 Months Ended |
Mar. 31, 2015 |
Equity [Abstract] | |
Equity | Equity |
|
Equity Plans |
We provide long-term incentives to eligible officers, directors, and employees in the form of equity-based awards. We maintain three equity incentive compensation plans, collectively described below as our Equity Plans: |
|
| | | | | | | | | | | | | | | | |
• | the 2000 Stock Option Plan (2000 Plan), | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
• | the 2010 Equity Incentive Plan (2010 Equity Plan), | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
• | the 2012 Equity Incentive Plan (2012 Equity Plan). | | | | | | | | | | | | | | | |
|
We issue new shares of common stock to satisfy awards issued under our Equity Plans. |
|
Stock Options |
Most of our stock options vest and become exercisable over a four to five year period and have a contractual life of 10 years. Certain stock options awarded are intended to qualify as incentive stock options pursuant to Section 422A of the Internal Revenue Code. |
|
The following table summarizes stock option activity under the Equity Plans for the six months ended March 31, 2015: |
|
| | | | | | |
| | | | | | | | | | | | | | | | |
| Number of Shares | | Weighted Average Exercise Price | | Weighted Average | | Aggregate Intrinsic Value (*) (in thousands) | | | | | | |
Remaining Contractual Life | | | | | | |
(in years) | | | | | | |
Outstanding as of September 30, 2014 | 1,431,190 | | | $19.06 | | | | | | | | | | |
| | | | | |
Granted | 9,650 | | | $5.34 | | | | | | | | | | |
| | | | | |
Exercised | (123,387 | ) | | $4.54 | | | | $ | 95 | | | | | | | |
| | | | | |
Forfeited | (8,027 | ) | | $5.12 | | | | | | | | | | |
Expired | (79,503 | ) | | $17.27 | | | | | | | | | | |
Outstanding as of March 31, 2015 | 1,229,923 | | | $20.62 | | 2.08 | | $ | 265 | | | | | | | |
| | | | | |
Exercisable as of March 31, 2015 | 1,210,320 | | | $20.86 | | 1.97 | | $ | 258 | | | | | | | |
| | | | | |
Vested and expected to vest as of March 31, 2015 | 1,226,293 | | | $20.66 | | 2.06 | | $ | 264 | | | | | | | |
| | | | | |
|
(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the six months ended March 31, 2014, the intrinsic value of options exercised was $4,000. |
|
As of March 31, 2015, there was approximately $0.2 million of unrecognized stock-based compensation expense, net of estimated forfeitures, related to non-vested stock options granted under the Equity Plans which is expected to be recognized over an estimated weighted average life of 3.3 years. |
|
Valuation Assumptions |
The fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option valuation model, adhering to the straight-line attribution approach using the following weighted-average assumptions, of which the expected term and stock price volatility rate are highly subjective: |
|
| | |
| | | | | | | | | | | | | | | | |
| For the Three Months Ended March 31, | | For the Six Months Ended March 31, | | |
| 2015 | | 2014 | | 2015 | | 2014 | | |
Black-Scholes weighted average assumptions: | | | | | | | | | |
Expected dividend rate | — | % | | — | % | | — | % | | — | % | | |
Expected stock price volatility rate | 72.7 | % | | 93.4 | % | | 76 | % | | 93.8 | % | | |
Risk-free interest rate | 1.7 | % | | 1.9 | % | | 1.8 | % | | 1.9 | % | | |
Expected term (in years) | 6 | | | 6 | | | 6 | | | 6 | | | |
| |
| | | | | | | | | |
Weighted average grant date fair value per share of stock options granted: | $3.51 | | $ | 3.76 | | | $ | 3.55 | | | $ | 3.79 | | | |
| |
|
Restricted Stock |
|
Restricted stock units (RSUs) granted under the 2010 Equity Plan and 2012 Equity Plan typically vest over 3 years and are subject to forfeiture if employment terminates prior to the lapse of the restrictions. RSUs are not considered issued or outstanding common stock until they vest. |
|
The following table summarizes the activity related to RSUs for the six months ended March 31, 2015: |
|
| | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Restricted Stock Activity | | Restricted Stock Units | | | | | | | | | | | |
| | Number of Shares | | Weighted Average Grant Date Fair Value | | | | | | | | | | | |
Non-vested as of September 30, 2014 | | 966,579 | | | $4.71 | | | | | | | | | | | |
| | | | | | | | | | |
Granted | | 507,400 | | | $5.36 | | | | | | | | | | | |
| | | | | | | | | | |
Vested | | (838,827 | ) | | $4.75 | | | | | | | | | | | |
Forfeited | | (41,949 | ) | | $4.86 | | | | | | | | | | | |
Non-vested as of March 31, 2015 | | 593,203 | | | $5.20 | | | | | | | | | | | |
| | | | | | | | | | |
|
As of March 31, 2015, there was approximately $2.7 million of remaining unamortized stock-based compensation expense, net of estimated forfeitures, associated with RSUs, which will be expensed over a weighted average remaining service period of approximately 2.5 years. The 0.6 million outstanding non-vested RSUs have an aggregate intrinsic value of approximately $3.2 million and a weighted average remaining contractual term of 1.6 years. For the six months ended March 31, 2015 and 2014, the intrinsic value of RSUs vested was $4.4 million and $1.6 million, respectively. Of the 0.6 million outstanding non-vested RSUs, approximately 0.5 million are expected to vest and have an aggregate intrinsic value of approximately $3.0 million and a weighted average remaining contractual term of 1.6 years. For the six months ended March 31, 2014, the weighted average grant date fair value of RSUs granted was $4.89. |
|
On December 10, 2014, in connection with the sale of the Photovoltaics Business and the change in control, 0.3 million RSU's vested. |
|
Stock-based compensation |
The effect of recording stock-based compensation expense was as follows: |
|
| |
| | | | | | | | | | | | | | | | |
Stock-based Compensation Expense - by award type | For the three months ended March 31, | | For the six months ended March 31, | |
(in thousands) | 2015 | | 2014 | | 2015 | | 2014 | |
Employee stock options | $ | 7 | | | $ | 29 | | | $ | 184 | | | $ | 78 | | |
|
Restricted stock awards and units | 797 | | | 424 | | | 2,056 | | | 918 | | |
|
Employee stock purchase plan | 14 | | | 75 | | | 64 | | | 163 | | |
|
401(k) match in common stock | 144 | | | 125 | | | 224 | | | 203 | | |
|
Outside director fees in common stock | 72 | | | 85 | | | 280 | | | 195 | | |
|
Total stock-based compensation expense | $ | 1,034 | | | $ | 738 | | | $ | 2,808 | | | $ | 1,557 | | |
|
|
|
| |
| | | | | | | | | | | | | | | | |
Stock-based Compensation Expense - by expense type | For the three months ended March 31, | | For the six months ended March 31, | |
(in thousands) | 2015 | | 2014 | | 2015 | | 2014 | |
Cost of revenue | $ | 81 | | | $ | 117 | | | $ | 185 | | | $ | 226 | | |
|
Selling, general, and administrative | 849 | | | 457 | | | 2,414 | | | 1,010 | | |
|
Research and development | 104 | | | 164 | | | 209 | | | 321 | | |
|
Total stock-based compensation expense | $ | 1,034 | | | $ | 738 | | | $ | 2,808 | | | $ | 1,557 | | |
|
|
|
The stock based compensation expense above relates to continuing operations. Included within discontinued operations is $0.1 million and $0.4 million of stock based compensation expense for the three months ended March 31, 2015 and 2014, respectively. Included within discontinued operations is $0.9 million and $0.7 million of stock based compensation expense for the six months ended March 31, 2015 and 2014. respectively. |
|
Income (Loss) Per Share |
The following table sets forth the computation of basic and diluted net income (loss) per share: |
|
|
| | | | | | | | | | | | | | | | |
Basic and Diluted Net (Loss) Income Per Share | | For the Three Months Ended March 31, | | For the Six Months Ended March 31, |
(in thousands, except per share) | | 2015 | | 2014 | | 2015 | | 2014 |
| | | | | | |
Numerator | | | | | | | | |
Loss from continuing operations | | $ | (956 | ) | | $ | (4,722 | ) | | $ | (4,086 | ) | | $ | (8,545 | ) |
Income (loss) from discontinued operations | | 4,008 | | | (710 | ) | | 63,266 | | | 1,059 | |
|
Total | | 3,052 | | | (5,432 | ) | | 59,180 | | | (7,486 | ) |
|
Undistributed earnings allocated to common shareholders for basic net income (loss) per share | | $ | 3,052 | | | $ | (5,432 | ) | | $ | 59,180 | | | $ | (7,486 | ) |
|
Undistributed earnings allocated to common shareholders for diluted net income (loss) per share | | $ | 3,052 | | | $ | (5,432 | ) | | $ | 59,180 | | | $ | (7,486 | ) |
|
Denominator: | | | | | | | | |
Denominator for basic net income (loss) per share - weighted average shares outstanding | | 32,077 | | | 30,392 | | | 31,640 | | | 30,162 | |
|
Dilutive options outstanding, unvested stock units and ESPP | | — | | | — | | | — | | | — | |
|
Denominator for diluted net income (loss) per share - adjusted weighted average shares outstanding | | 32,077 | | | 30,392 | | | 31,640 | | | 30,162 | |
|
| | | | | | | | |
Net income (loss) per basic and diluted shares: | | | | | | | | |
Continuing operations | | $ | (0.03 | ) | | $ | (0.16 | ) | | $ | (0.13 | ) | | $ | (0.28 | ) |
Discontinued operations | | 0.13 | | | (0.02 | ) | | 2 | | | 0.03 | |
|
Net income (loss) per basic share | | $ | 0.1 | | | $ | (0.18 | ) | | $ | 1.87 | | | $ | (0.25 | ) |
|
| | | | | | | | |
Weighted average antidilutive options, unvested restricted stock units and awards, warrants and ESPP shares excluded from the computation | | 2,214 | | | 3,028 | | | 2,434 | | | 2,653 | |
|
| | | | | | | | |
Average market price of common stock | | $ | 5.34 | | | $ | 4.96 | | | $ | 5.32 | | | $ | 5 | |
|
|
The antidilutive stock options, unvested stock and warrants were excluded from the computation of diluted net income (loss) per share due to the assumed proceeds from the award’s exercise or vesting being greater than the average market price of the common shares or due to the Company incurring a net loss for the periods presented. |
Employee Stock Purchase Plan |
We maintain an Employee Stock Purchase Plan (ESPP) that provides employees an opportunity to purchase common stock through payroll deductions. The ESPP is a 6-month duration plan with new participation periods beginning on February 25 and August 26 of each year. The purchase price is set at 85% of the average high and low market price of our common stock on either the first or last day of the participation period, whichever is lower, and contributions are limited to the lower of 10% of an employee's compensation or $25,000. |
|
Future Issuances |
|
As of March 31, 2015, we had common stock reserved for the following future issuances: |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Future Issuances | Number of Common Stock Shares Available for Future Issuances | | | | | | | | | | | | | | |
Exercise of outstanding stock options | 1,229,923 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Unvested restricted stock units | 593,203 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Purchases under the employee stock purchase plan | 1,020,874 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Issuance of stock-based awards under the Equity Plans | 612,707 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Exercise of outstanding warrants | 400,001 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Purchases under the officer and director share purchase plan | 88,741 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Total reserved | 3,945,449 | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |